loading
전일 마감가:
$8.73
열려 있는:
$8.67
하루 거래량:
757.99K
Relative Volume:
0.59
시가총액:
$650.95M
수익:
-
순이익/손실:
$-297.11M
주가수익비율:
-2.1375
EPS:
-4.38
순현금흐름:
$-216.95M
1주 성능:
+3.08%
1개월 성능:
-39.63%
6개월 성능:
-12.67%
1년 성능:
+29.96%
1일 변동 폭
Value
$8.61
$9.61
1주일 범위
Value
$8.495
$9.61
52주 변동 폭
Value
$6.065
$19.71

Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile

Name
명칭
Phathom Pharmaceuticals Inc
Name
전화
(877) 742-8466
Name
주소
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Name
직원
112
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
PHAT's Discussions on Twitter

PHAT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
PHAT 9.36 650.95M 0 -297.11M -216.95M -4.38
VRTX 450.00 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.18 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.92 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.91 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.24 24.89B 3.30B -501.07M 1.03B 11.54

Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-08-09 개시 H.C. Wainwright Buy
2023-05-11 업그레이드 Evercore ISI In-line → Outperform
2023-03-13 개시 Craig Hallum Buy
2022-10-21 개시 Jefferies Buy
2022-05-06 다운그레이드 Evercore ISI Outperform → In-line
2021-05-12 업그레이드 Goldman Sell → Neutral
2021-02-17 개시 BMO Capital Markets Outperform
2021-02-02 개시 Guggenheim Buy
2020-06-26 다운그레이드 Goldman Neutral → Sell
2019-11-20 개시 Evercore ISI Outperform
2019-11-19 개시 Goldman Neutral
2019-11-19 개시 Jefferies Buy
2019-11-19 개시 Needham Buy
모두보기

Phathom Pharmaceuticals Inc 주식(PHAT)의 최신 뉴스

pulisher
05:30 AM

Jennison Associates LLC Grows Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat

05:30 AM
pulisher
Nov 19, 2024

Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Phathom Pharmaceuticals - The Healthcare Technology Report.

Nov 19, 2024
pulisher
Nov 14, 2024

(PHAT) Proactive Strategies - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 11, 2024

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024
pulisher
Nov 11, 2024

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Up 115.60% This Year: What Is Going To Happen Next - Stocks Register

Nov 11, 2024
pulisher
Nov 11, 2024

Phathom Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Business Updates - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 8.9%Here's What Happened - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlig - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Phathom Pharmaceuticals Reports Significant Revenue Growth - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire

Nov 07, 2024
pulisher
Nov 06, 2024

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Report Previ - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

Jennison Associates LLC's Strategic Acquisition in Phathom Pharm - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 04, 2024
pulisher
Nov 01, 2024

Investors bid Phathom Pharmaceuticals (NASDAQ:PHAT) up US$75m despite increasing losses YoY, taking one-year return to 96% - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Phathom Pharmaceuticals (PHAT) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

PHAT SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action InvestigationPHAT - Marketscreener.com

Oct 30, 2024
pulisher
Oct 28, 2024

Phathom Pharmaceuticals to Report Third Quarter 2024 - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business - The Bakersfield Californian

Oct 28, 2024
pulisher
Oct 28, 2024

Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024 - StockTitan

Oct 28, 2024
pulisher
Oct 27, 2024

Phathom Pharmaceuticals to Present VOQUEZNA® Data at the - GlobeNewswire

Oct 27, 2024
pulisher
Oct 27, 2024

Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting - Yahoo Finance

Oct 27, 2024
pulisher
Oct 23, 2024

Where are the Opportunities in (PHAT) - Stock Traders Daily

Oct 23, 2024
pulisher
Oct 22, 2024

Some of the Gastroesophageal Reflux Disease Therapeutics market players are: - InsightAce Analytic

Oct 22, 2024
pulisher
Oct 20, 2024

Shareholders have faith in loss-making Phathom Pharmaceuticals (NASDAQ:PHAT) as stock climbs 6.6% in past week, taking one-year gain to 74% - Simply Wall St

Oct 20, 2024
pulisher
Oct 19, 2024

Creative Planning Has $278,000 Stock Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Oct 19, 2024
pulisher
Oct 18, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 6.8%Time to Buy? - MarketBeat

Oct 18, 2024
pulisher
Oct 17, 2024

Certain Common Stock of Phathom Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-OCT-2024. - Marketscreener.com

Oct 17, 2024
pulisher
Oct 15, 2024

Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

A year in review: Phathom Pharmaceuticals Inc (PHAT)’s performance in the last year - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 3.4%Time to Sell? - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

PHAT’s 52-Week Rollercoaster: From $6.07 to $19.71 – What’s Next for Investors? - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Financial Health Report: Phathom Pharmaceuticals Inc (PHAT)’s Ratios Tell a Tale - The Dwinnex

Oct 14, 2024
pulisher
Oct 13, 2024

Learn to Evaluate (PHAT) using the Charts - Stock Traders Daily

Oct 13, 2024
pulisher
Oct 11, 2024

A stock that deserves closer examination: Phathom Pharmaceuticals Inc (PHAT) - US Post News

Oct 11, 2024
pulisher
Oct 11, 2024

PHAT Stock Sees Decline of Approximately -13.44% in Last Five Days - Knox Daily

Oct 11, 2024
pulisher
Oct 10, 2024

PHAT Stock: A Comprehensive Analysis and Forecast - The InvestChronicle

Oct 10, 2024
pulisher
Oct 08, 2024

PHAT (Phathom Pharmaceuticals Inc) may reap gains as insiders became active recently - Knox Daily

Oct 08, 2024
pulisher
Oct 07, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 7.5%Here's What Happened - MarketBeat

Oct 07, 2024
pulisher
Oct 07, 2024

Daily Market Movement: Phathom Pharmaceuticals Inc (PHAT) Sees a -4.96 Decrease, Closing at 17.25 - The Dwinnex

Oct 07, 2024
pulisher
Oct 07, 2024

A new trading data show Phathom Pharmaceuticals Inc (PHAT) is showing positive returns. - SETE News

Oct 07, 2024
pulisher
Oct 07, 2024

Marshall Wace LLP Invests $1.16 Million in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Phathom Pharmaceuticals Inc Inc. (PHAT) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Oct 04, 2024
pulisher
Oct 03, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 4.8%Here's Why - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

The Potential Rise in the Price of Phathom Pharmaceuticals Inc (PHAT) following insiders activity - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Have you been able to find a good deal on Phathom Pharmaceuticals Inc’s shares? - US Post News

Oct 02, 2024
pulisher
Sep 30, 2024

Phathom Pharmaceuticals Inc (PHAT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Its Stock Has Paid Off Big Time For Phathom Pharmaceuticals Inc - SETE News

Sep 30, 2024

Phathom Pharmaceuticals Inc (PHAT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Phathom Pharmaceuticals Inc 주식 (PHAT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Henderson Molly
CFO and CBO
Jul 15 '24
Sale
11.72
4,325
50,689
99,447
Curran Terrie
President and Chief Executive
Jul 15 '24
Sale
11.72
33,848
396,699
377,734
Henderson Molly
CFO and CBO
Apr 08 '24
Sale
11.10
3,435
38,128
95,263
Curran Terrie
President and Chief Executive
Mar 22 '24
Sale
9.11
16,851
153,513
410,784
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Jan 24 '24
Sale
8.10
3,703,703
29,999,994
3,755,583
Henderson Molly
CFO and CBO
Jan 19 '24
Sale
7.75
6,307
48,900
98,698
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):